| Lastest Insider Transactions Of OptimizeRx Corp ( OPRX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | Chief Legal & Admin Officer | 2026-02-11 | Option Exercise | 4,000 | 0.00 | 0 | 2026-02-13 11:49:55 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | 2025-12-19 | Option Exercise | 5,237 | 0.00 | 0 | 2025-12-23 14:23:07 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | 2025-12-19 | Sell | 1,388 | 13.51 | 18,752 | 2025-12-22 10:10:47 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | 2025-12-19 | Option Exercise | 5,237 | 0.00 | 0 | 2025-12-22 10:10:47 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Executive Officer | 2025-12-19 | Option Exercise | 6,546 | 0.00 | 0 | 2025-12-22 10:10:09 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | Chief Legal & Admin Officer | 2025-12-19 | Option Exercise | 3,928 | 0.00 | 0 | 2025-12-22 10:09:28 |
| OPRX | OptimizeRx Corp | Besch Doug | Chief Product & Tech Officer | 2025-12-19 | Option Exercise | 1,964 | 0.00 | 0 | 2025-12-22 10:07:15 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | Chief Legal & Admin Officer | 2025-10-03 | Option Exercise | 6,649 | 0.00 | 0 | 2025-10-07 18:46:15 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Executive Officer | 2025-10-03 | Sell | 1,620 | 18.75 | 30,375 | 2025-10-07 18:26:20 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Executive Officer | 2025-10-03 | Option Exercise | 6,649 | 0.00 | 0 | 2025-10-07 18:26:20 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | Chief Finance & Strat Officer | 2025-10-03 | Option Exercise | 16,623 | 0.00 | 0 | 2025-10-07 18:25:59 |
| OPRX | OptimizeRx Corp | Besch Doug | Chief Product & Tech Officer | 2025-10-03 | Option Exercise | 3,325 | 0.00 | 0 | 2025-10-07 17:52:24 |
| OPRX | OptimizeRx Corp | Spangler Patrick D | Directior | 2025-08-28 | Sell | 11,120 | 17.49 | 194,489 | 2025-09-11 13:55:07 |
| OPRX | OptimizeRx Corp | Lang James Paul | Directior | 2025-03-14 | Buy | 321,408 | 7.60 | 2,443,762 | 2025-03-19 19:40:24 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2025-03-01 | Option Exercise | 1,928 | 0.00 | 0 | 2025-03-04 09:18:21 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | Chief Legal Officer & CHRO | 2025-03-01 | Option Exercise | 771 | 0.00 | 0 | 2025-03-04 09:16:52 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2025-02-11 | Option Exercise | 4,000 | 0.00 | 0 | 2025-02-13 15:58:00 |
| OPRX | OptimizeRx Corp | KLEMA CATHY | Directior | 2025-02-02 | Option Exercise | 5,109 | 0.00 | 0 | 2025-02-04 18:50:31 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2024-12-19 | Option Exercise | 3,927 | 0.00 | 0 | 2024-12-20 19:48:14 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2024-12-19 | Option Exercise | 6,546 | 0.00 | 0 | 2024-12-20 19:47:42 |
| OPRX | OptimizeRx Corp | Besch Doug | Chief Product Officer | 2024-12-19 | Option Exercise | 1,964 | 0.00 | 0 | 2024-12-20 19:47:09 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2024-12-19 | Option Exercise | 5,237 | 0.00 | 0 | 2024-12-20 19:46:38 |
| OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CEO | 2024-12-12 | Buy | 20,000 | 5.01 | 100,220 | 2024-12-16 14:28:39 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2024-11-08 | Option Exercise | 1,785 | 0.00 | 0 | 2024-11-12 09:37:56 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2024-10-11 | Option Exercise | 8,222 | 0.00 | 0 | 2024-10-15 16:53:39 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2024-10-03 | Option Exercise | 16,622 | 0.00 | 0 | 2024-10-07 21:30:16 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2024-10-03 | Option Exercise | 6,649 | 0.00 | 0 | 2024-10-07 21:26:39 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2024-10-03 | Option Exercise | 6,649 | 0.00 | 0 | 2024-10-07 21:24:44 |
| OPRX | OptimizeRx Corp | Besch Doug | Chief Product Officer | 2024-10-03 | Option Exercise | 3,324 | 0.00 | 0 | 2024-10-07 21:24:06 |
| OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CEO | 2024-04-18 | Option Exercise | 28,895 | 0.00 | 0 | 2024-06-12 11:41:35 |
| OPRX | OptimizeRx Corp | Spangler Patrick D | Directior | 2024-06-05 | Option Exercise | 10,061 | 0.00 | 0 | 2024-06-11 17:50:28 |
| OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Directior | 2024-06-05 | Option Exercise | 10,061 | 0.00 | 0 | 2024-06-11 17:49:49 |
| OPRX | OptimizeRx Corp | WASSON GREGORY D | Directior | 2024-06-05 | Option Exercise | 10,061 | 0.00 | 0 | 2024-06-11 17:48:48 |
| OPRX | OptimizeRx Corp | HALAS GUS D | Directior | 2024-06-05 | Option Exercise | 10,061 | 0.00 | 0 | 2024-06-11 17:48:18 |
| OPRX | OptimizeRx Corp | Lang James Paul | Directior | 2024-06-05 | Option Exercise | 10,061 | 0.00 | 0 | 2024-06-11 17:46:59 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2024-05-02 | Option Exercise | 90,000 | 0.00 | 0 | 2024-05-06 21:35:52 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2024-03-01 | Option Exercise | 1,927 | 0.00 | 0 | 2024-05-06 21:34:27 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2023-10-11 | Option Exercise | 8,221 | 0.00 | 0 | 2024-04-22 08:37:09 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2024-03-01 | Option Exercise | 1,927 | 0.00 | 0 | 2024-03-06 16:20:28 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2024-03-01 | Option Exercise | 771 | 0.00 | 0 | 2024-03-06 16:19:04 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2024-02-11 | Option Exercise | 4,000 | 0.00 | 0 | 2024-02-13 18:16:31 |
| OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CEO | 2024-01-09 | Option Exercise | 9,628 | 0.00 | 0 | 2024-01-18 17:56:07 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2024-01-09 | Sell | 4,000 | 15.19 | 60,751 | 2024-01-11 17:06:09 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2023-11-08 | Option Exercise | 1,785 | 0.00 | 0 | 2023-11-13 14:32:54 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2022-10-11 | Option Exercise | 14,376 | 0.00 | 0 | 2023-10-12 14:18:29 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2023-10-03 | Option Exercise | 6,649 | 0.00 | 0 | 2023-10-06 14:47:51 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2023-10-03 | Option Exercise | 6,649 | 0.00 | 0 | 2023-10-06 14:47:39 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2023-10-03 | Option Exercise | 16,662 | 0.00 | 0 | 2023-10-06 14:47:21 |
| OPRX | OptimizeRx Corp | Besch Doug | Chief Product Officer | 2023-10-03 | Option Exercise | 3,324 | 0.00 | 0 | 2023-10-06 14:47:06 |
| OPRX | OptimizeRx Corp | HALAS GUS D | Directior | 2023-06-07 | Option Exercise | 4,637 | 0.00 | 0 | 2023-08-18 10:03:29 |
| OPRX | OptimizeRx Corp | Spangler Patrick D | Directior | 2023-06-07 | Option Exercise | 4,637 | 0.00 | 0 | 2023-08-18 09:33:33 |
| OPRX | OptimizeRx Corp | Lang James Paul | Directior | 2023-06-07 | Option Exercise | 4,637 | 0.00 | 0 | 2023-08-18 09:31:24 |
| OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Directior | 2023-06-07 | Option Exercise | 4,637 | 0.00 | 0 | 2023-08-18 09:29:34 |
| OPRX | OptimizeRx Corp | WASSON GREGORY D | Directior | 2023-06-07 | Option Exercise | 4,637 | 0.00 | 0 | 2023-08-18 09:28:06 |
| OPRX | OptimizeRx Corp | Lang James Paul | Directior | 2023-03-30 | Option Exercise | 657 | 0.00 | 0 | 2023-04-03 12:22:45 |
| OPRX | OptimizeRx Corp | HALAS GUS D | Directior | 2023-03-30 | Option Exercise | 657 | 0.00 | 0 | 2023-04-03 12:22:28 |
| OPRX | OptimizeRx Corp | WASSON GREGORY D | Directior | 2023-03-31 | Option Exercise | 657 | 0.00 | 0 | 2023-04-03 12:22:11 |
| OPRX | OptimizeRx Corp | Spangler Patrick D | Directior | 2023-03-31 | Option Exercise | 657 | 0.00 | 0 | 2023-04-03 12:19:49 |
| OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Directior | 2023-03-31 | Option Exercise | 657 | 0.00 | 0 | 2023-04-03 12:18:04 |
| OPRX | OptimizeRx Corp | Stelmakh Edward | CFO/COO | 2022-10-11 | Option Exercise | 8,221 | 0.00 | 0 | 2023-03-30 12:19:41 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2023-03-01 | Option Exercise | 771 | 0.00 | 0 | 2023-03-03 15:41:00 |
| OPRX | OptimizeRx Corp | Silvestro Stephen L | Chief Commercial Officer | 2023-03-01 | Option Exercise | 1,927 | 0.00 | 0 | 2023-03-03 15:40:35 |
| OPRX | OptimizeRx Corp | Inman Todd | Chief Technology Officer | 2023-03-01 | Option Exercise | 771 | 0.00 | 0 | 2023-03-03 15:31:50 |
| OPRX | OptimizeRx Corp | Odence-Ford Marion | General Counsel and CCO | 2023-02-11 | Option Exercise | 4,000 | 0.00 | 0 | 2023-02-14 11:32:14 |
| OPRX | OptimizeRx Corp | FEBBO WILLIAM J | CEO | 2023-01-07 | Option Exercise | 9,628 | 0.00 | 0 | 2023-01-31 16:50:44 |
| OPRX | OptimizeRx Corp | HALAS GUS D | Directior | 2022-12-30 | Option Exercise | 409 | 0.00 | 0 | 2023-01-04 16:10:12 |
| OPRX | OptimizeRx Corp | WASSON GREGORY D | Directior | 2022-12-30 | Option Exercise | 409 | 0.00 | 0 | 2023-01-04 16:07:52 |
| OPRX | OptimizeRx Corp | Vos Ellen O'Connor | Directior | 2022-12-30 | Option Exercise | 409 | 0.00 | 0 | 2023-01-04 16:06:26 |
| OPRX | OptimizeRx Corp | Spangler Patrick D | Directior | 2022-12-30 | Option Exercise | 409 | 0.00 | 0 | 2023-01-04 16:04:56 |
| OPRX | OptimizeRx Corp | Lang James Paul | Directior | 2022-12-30 | Option Exercise | 409 | 0.00 | 0 | 2023-01-04 16:04:03 |
